Speaker Profile
M.D., CEO and Co-founder, Inmedix
Biography
Andrew Holman is a clinical rheumatologist who discovered and published the role of dopamine agonists (Parkinson's disease medications) as a leading treatment for fibromyalgia (FM). This work, combined with the immunology training of rheumatology, led to exploration of how stress impacts autoimmune disease onset, activity, treatment response and potential remission. The concept is called immuno-autonomics and it is revolutionizing how doctors address stress biology, first in autoimmune disease, and next, in other diseases adversely impacted by stress.
Clinical Dx Showcase:
Inmedix
Seattle-based Inmedix is bringing next-generation heart rate variability (HRV) to clinicians on a high-fidelity ECG platform with data analyzed in real-time in the cloud.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
